Clinical Research
Filter News
Found 107,853 articles
-
In the cannabis sector of drug development, there is a movement happening. And Rob Davidson, chief executive officer of CURE Pharmaceuticals is making sure his company is ready for the next steps.
-
March is National Kidney Month, with March 14 designated as World Kidney Day. The kidneys are called the body’s chemical factories. Their job is to filter waste and perform specific important jobs like controlling red blood cell production and blood pressure.
-
UK Schools Rank Last in Providing Oral Health Education, FDI Survey of 13 Countries Says
3/20/2019
World Oral Health Day, FDI World Dental Federation released the results of a survey from 13 countries, which asked parents with children aged 5–16 if their child's school provided lessons on good oral care.
-
Washington, Michigan and Wisconsin See Flu Activity Gains
3/20/2019
Walgreens Flu Index for week ending March 16, 2019
-
Leading Analytics Vendors' Capabilities Expand the Value of Healthcare Provider Data and Reach of Applications to Address Enterprise Performance Management
3/20/2019
Healthcare providers are recognizing the value of increasing volumes of data they hold and expanding their use of mainstream and advanced analytics solutions to more use cases and more user groups
-
Takeda and HemoShear Therapeutics Extend Exclusive Drug Discovery Partnership in Liver Diseases
3/20/2019
HemoShear Therapeutics, LLC announced an extension of its partnership with Takeda Pharmaceutical Company Limited to discover and develop additional novel therapeutics for liver diseases, including nonalcoholic steatohepatitis.
-
Pharmaceutical Collaborations and Rare Diseases Drive the Drugs to Watch as New Blockbusters Are Forecast to Hit the Market in 2019
3/20/2019
New report from Clarivate Analytics identifies seven new drugs predicted to achieve annual sales of >$1 billion by 2023
-
New Data From The Aesthetic Society Delineates The Top 5 Procedures Performed By Plastic Surgeons In The U.S. And The Rise In Patient Demand For Nonsurgical Options
3/20/2019
The American Society for Aesthetic Plastic Surgery, (The Aesthetic Society) has just released its annual statistics for 2018
-
AlzeCure Initiates New Drug Project Within Pain
3/20/2019
AlzeCure Pharma AB announced that it has started a new preclinical drug project, TrkA-NAM, which is based on the company's research platform NeuroRestore.
-
Dyve Bioscience Announces Positive Results from Pilot Study in Gout Pain at European Crystal Network Workshop 2019
3/20/2019
Topical, transdermal sodium bicarbonate treatment significantly and safely reduced pain associated with an acute gout flare
-
CalciMedica, Inc. to Present Study Population Profile from its Initial Patient Study of its CRAC Channel Inhibitor CM4620 in Acute Pancreatitis at International Conference
3/20/2019
Physicians from several study sites involved in CalciMedica's initial acute pancreatitis clinical study of its CRAC channel inhibitor CM4620 and CalciMedica, Inc., presented a poster at the 39th International Symposium on Intensive Care and Emergency Medicine being held in Brussels on March 19-22.
-
2019 Health Care Industry Reports Reveal How Technology Adoption Impacts Medication Access
3/20/2019
According to the newly-released ePA National Adoption Scorecard and the Real-Time Benefit Check National Adoption Scorecard, most EHRs, health systems, payers and pharmacies have committed to electronic prior authorization (ePA) and real-time benefit check solutions; however, attaining patient-benefit from these platforms relies on broader provider utilization.
-
“With this drug, we are not only preventing that first heart attack, but potentially the second stroke and maybe that third fatal event,” stated Deepak Bhatt, the study’s lead investigator.
-
March is National Women’s Month with March 8 specifically designated as International Women’s Day. Although this is not remotely a comprehensive list, BioSpace recognizes these 10 women (in no particular order) as being especially influential in the biopharma industry.
-
In a Phase III trial, a higher proportion of deaths was observed in the venetoclax arm compared to the control arm of the trial.
-
The company announced positive topline results from its Phase III EMPOWUR trial of viregron in patients with overactive bladder.
-
Esperion, based in Ann Arbor, Mich., announced results from its Phase III Study 2 of bempedoic acid at the American College of Cardiology (ACC) annual meeting.
-
Allergan, which has been a leader in the migraine space, hopes to have a new treatment available for patients using a new mechanism of action for acute treatment of migraine.
-
Department of Defense Prostate Cancer Research Program Funding Opportunities for Fiscal Year 2019 (FY19)
3/19/2019
The FY19 Defense Appropriation provides $100 million to the Department of Defense Prostate Cancer Research Program to support innovative, high-impact prostate cancer research.
-
GeoVax Ebola Vaccine Study Published in the Atlas of Science
3/19/2019
GeoVax Ebola Vaccine Provides Potential for 100% Protection from Single-Dose